{"id":"https://genegraph.clinicalgenome.org/r/8fe65d69-4f32-4fb5-b00c-55cf314dc4e2v2.0","type":"EvidenceStrengthAssertion","dc:description":"VCL was originally curated for DCM by the ClinGen GCEP on 04/10/2020. Evidence of the association of this gene with DCM was re-evaluated using SOP v10 on 08/09/2024. As a result, the classification did change. A summary of the information contributing to the classification of this gene at the time of re-evaluation is summarized herein.\n\nVCL was first reported in relation to autosomal dominant dilated cardiomyopathy (DCM) in 2011 (Wells et al, 2011, PMID: 24062880). VCL encodes a mechanosensitive protein incorporated in Z-disks, of which two splicing isoforms are produced. Metavinculin is 68 residues longer than vinculin, with exon 19 additionally spliced in, and both isoforms are expressed in the human heart. \n\nHuman genetic evidence supporting this gene-disease relationship include case-level data and case-control data. A study on 350 DCM patients sequenced on exon 19 identified 2 distinct VCL variants (one missense and one inframe deletion) in 3 patients, both absent in 500 controls. Using viscometry analysis, authors demonstrated that both variants alter actin filament organization, and confirmed this using electron microscopy. In addition, they demonstrated that the missense variant also causes disruption of the intercalated discs (Olson et al, 2002, PMID 11815424). Wells et al. (2011, PMID: 24062880) reported a missense variant segregating in a family with DCM. Given that segregation in this family was not scorable, the VCL missense variant segregating in the family was considered case-level evidence. In 2020, a large cohort-based study - comprising a primary cohort of 1040 patients and a secondary cohort of 1498 patients - highlighted a significant enrichment of predicted protein-truncating variants in the secondary cohort compared with the ExAC population database (Mazzarotto et al, 2020, PMID: 31983221). In the primary cohort, one proband was found to carry a predicted loss-of-function variant in VCL, which was scored as case-level evidence, and 10 others were found to carry 8 distinct rare missense variants.  Given a general lack of substantial evidence in support of VCL missense variantsâ€™ pathogenicity, isolated missense variants in absence of any supportive evidence were not scored in this curation effort. As a result, only one variant among the aforementioned 8 was scored, as its recurrence in unrelated probands (N=3) was considered supportive of pathogenicity. A second large cohort-based study demonstrated again significant enrichment of rare, predicted protein-truncating VCL variants in 3118 DCM patients (of which 1624 overlapping those analyzed by Mazzarotto et al) compared with population individuals (Hawley et al, 2020, PMID: 32516855). Six variants carried by DCM patients not overlapping those used to score case-control enrichment in Mazzarotto et al were scored as case-level evidence, with scores adjusted based on available evidence (e.g. presence/absence of family information, presence/absence of other variants, genes screened etc). In 2023 a new study describing 5 families with DCM and rare VCL loss-of-function variants (including 3 previously described in 2022, but scored here) was published (Zahavic et al, 2023, PMID 37548861). None of the families was scorable for segregation, but all 5 were scored as case-level evidence, again with individual scores adjusted according to e.g. the presence/absence of other potentially pathogenic variants. \n\nThis gene-disease assertion is supported also by experimental evidence, comprising in vitro protein-protein interaction assays, expression studies and animal models. Direct protein-protein interaction with cardiac muscle alpha actin (encoded by ACTC1, classified as a moderate-evidence gene for DCM) and with nebulin-related anchoring protein (NRAP, strong-evidence gene for AR DCM) were demonstrated in 1981 using in vitro viscometry analysis and light and electron microscopy (Jockusch et al, 1981, PMID: 6789327), and in 1999 using ELISA (Luo et al, 1999, PMID 10320340), respectively.  A study on 33 human heart specimens detected deficiency of both mRNA and protein expression in a patient with DCM (Maeda et al, 1997, PMID: 8994410). In addition, Zemljic-Harpf et al described how VCL knock-out mice showed progressive dilation of the left ventricle and a parallel decline of left-ventricular function (Zemljic-Harpf et al, 2007, PMID: 17785437). \n\nIn summary, there is strong evidence to support this gene-disease relationship. More evidence is needed to consider VCL a definitive DCM gene, as the majority of the points assigned are related to case-level evidence. This classification was approved by the ClinGen Dilated Cardiomyopathy Working Group on August 9, 2024 (SOP Version 10).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/8fe65d69-4f32-4fb5-b00c-55cf314dc4e2","GCISnapshot":"https://genegraph.clinicalgenome.org/r/2d46699a-5f8c-460d-9233-bec4e2ecf560","calculatedEvidenceStrength":"Strong","changes":[{"id":"cg:sopChange"},{"id":"cg:newEvidence"},{"id":"cg:summaryChange"},{"id":"cg:classificationChange"},{"id":"cg:otherTextChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/2d46699a-5f8c-460d-9233-bec4e2ecf560_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10035","date":"2024-08-09T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/2d46699a-5f8c-460d-9233-bec4e2ecf560_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10035","date":"2025-08-07T12:25:20.879Z","role":"Publisher"}],"curationReasons":["RecurationTiming"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2d46699a-5f8c-460d-9233-bec4e2ecf560_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2d46699a-5f8c-460d-9233-bec4e2ecf560_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7fc3074c-5c04-4cb3-9c11-213b7db0d6e8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/57e74f64-5be9-4895-bf1c-72c6cda940dd","type":"Finding","dc:description":"Authors analysed 33 human heart specimens, 23 of which from individuals affected with idiopathic DCM. PCR and Western Blotting reveal deficiency of both cardiac metavinculin mRNA and protein in one individual (called IDC-2) affected with DCM. Relative abundances of vinculin (i.e. not metavinculin) and alpha-actinin were similar in all analysed samples. PCR detected vinculin at levels comparable to those of all other samples in the IDC-2 individual with lack of metavinculin.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8994410","rdfs:label":"PCR and WB on vinculin/metavinculin in 33 heart samples","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6cb79e67-d17f-478e-a5d3-70f3625ab10c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d19721ab-7cce-40da-8913-166092e172e8","type":"Finding","dc:description":"NRAP is classified as strong by DCM GCEP. Panel C showed binding of nebulin-like super repeat region of NRAP (N-RAP-SR) with vinculin significantly above control. Panel D showed specific binding with NRAP after subtracting control binding. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10320340","rdfs:label":"Luo_interaction","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d8a85845-af48-453e-b6d1-274d10a6387d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e646f98a-1806-41b6-bb7f-6da0e0477179","type":"Finding","dc:description":"From the manuscript: \"Our finding that vinculin is capable of bundling actin filaments very effectively into paracristalline structures (Fig. 7) indicate that vinculin interacts directly with actin. [...] The effect of vinculin on actin viscosity as measured under conditions of low shear is reminescent of the results obtained with actin capping protein from Acanthamoeba: however, in contrast to the capping protein, vinculin does not inhibit growth of S1-decorated filament fragments. Thus, vinculin probably binds laterally to actin filaments.In the cell, both proteins were localized by antibody binding very close to the cytoplasmic side of the plasma membrane.\"\n\nCardiac actin (ACTC1) has been implicated in DCM in a great number of publications. Curation by Clingen still pending.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/6789327","rdfs:label":"In vitro viscometry analysis and light/electron microscopy","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2d46699a-5f8c-460d-9233-bec4e2ecf560_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8614dd9d-d998-403a-b92c-3aaa6983bdb4","type":"EvidenceLine","dc:description":"A very high proportion (49%) of the mice died of SCD before 3 months of age","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/affedf6d-07e9-453d-89b6-085cda47e914","type":"Finding","dc:description":"Authors describe a progressive dilation of the left ventricle in systole and diastole in the KO mice who survived through the 'vulnerable SCD period' (first 3 months, during which 49% mice died of SCD), which paralleled the decline in overall ventricular function, evidenced by reduction of percent fractional shortening (%FS) and velocity of circumferential fiber shortening (Vcf). These findings are consistent with a dilated cardiomyopathy which developed as the mice aged.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17785437","rdfs:label":"Knock-out of VCL in mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/2d46699a-5f8c-460d-9233-bec4e2ecf560_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2d46699a-5f8c-460d-9233-bec4e2ecf560_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7f623e43-025d-4d4a-a5da-7d98221cdcce_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37548861","rdfs:label":"Zahavic_family 2","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/7f623e43-025d-4d4a-a5da-7d98221cdcce","type":"Family","rdfs:label":"Zahavic_family 2","member":{"id":"https://genegraph.clinicalgenome.org/r/469dc255-3465-4599-9e81-b9cbbb788a08","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37548861","rdfs:label":"Zahavic_II","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/25009b5b-662a-4941-ae01-abf91511da82","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.3(VCL):c.3115C>T (p.Gln1039Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA273293"}},"detectionMethod":"Whole genome sequencing with variants in VCL confirmed by clinical genetic testing. Sequencing workflow was previously reported in paper PMID: 35288587.","firstTestingMethod":"Whole genome shotgun sequencing","secondTestingMethod":"Next generation sequencing panels","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e63c0f2f-d1eb-4a55-8963-3aaaa9bd2fdf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37548861","allele":{"id":"https://genegraph.clinicalgenome.org/r/25009b5b-662a-4941-ae01-abf91511da82"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/469dc255-3465-4599-9e81-b9cbbb788a08"}},{"id":"https://genegraph.clinicalgenome.org/r/9de0cb34-172e-4839-87b8-378b58fd413c_proband_segregation","type":"FamilyCosegregation","dc:description":"Considering also individuals I-2 and II-2 as obligate carriers, and excluding individual IV-2 given the presence of 'ventricular dilation' but not DCM, the pedigree counts only 3 segregations.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11815424","rdfs:label":"K-4252","family":{"id":"https://genegraph.clinicalgenome.org/r/9de0cb34-172e-4839-87b8-378b58fd413c","type":"Family","rdfs:label":"K-4252","member":{"id":"https://genegraph.clinicalgenome.org/r/222ec13f-6423-4a98-bbee-7e83f4b9830a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11815424","rdfs:label":"K-4252 - III.2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":57,"allele":{"id":"https://genegraph.clinicalgenome.org/r/7baa39a8-6a22-44d9-8c1b-7259df779c20","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.2(VCL):c.2923C>T (p.Arg975Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA121939"}},"detectionMethod":"Oligonucleotide primers were designed to amplify the coding and splice junction regions of the metavinculin-specific insert of vinculin (exon 19 of the VCL gene).Sequence variants were identified by single-strand conformation polymorphism (SSCP) analyses and cycle sequencing. The presence of variants in ACTC1 and TPM1 was excluded previously.","firstTestingMethod":"SSCP","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/cd55b404-d2e9-4a59-b3d6-ba0c93d302be_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11815424","allele":{"id":"https://genegraph.clinicalgenome.org/r/7baa39a8-6a22-44d9-8c1b-7259df779c20"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/222ec13f-6423-4a98-bbee-7e83f4b9830a"}},{"id":"https://genegraph.clinicalgenome.org/r/e0b61268-7a27-4375-8470-1ed7dac4b4f8_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11815424","rdfs:label":"K-785","family":{"id":"https://genegraph.clinicalgenome.org/r/e0b61268-7a27-4375-8470-1ed7dac4b4f8","type":"Family","rdfs:label":"K-785","member":{"id":"https://genegraph.clinicalgenome.org/r/4a06e23e-04ba-4b42-95ca-50524f50c3ad","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11815424","rdfs:label":"K-785 - II.1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":30,"allele":{"id":"https://genegraph.clinicalgenome.org/r/b65476fd-dae5-4cb7-ad03-1284f7cd11aa","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.3(VCL):c.2801C>T (p.Ala934Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA136752"}},"detectionMethod":"Oligonucleotide primers were designed to amplify the coding and splice junction regions of the metavinculin-specific insert of vinculin (exon 19 of the VCL gene).Sequence variants were identified by single-strand conformation polymorphism (SSCP) analyses and cycle sequencing. The presence of variants in ACTC1 and TPM1 was excluded previously.","firstTestingMethod":"SSCP","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/1ca91faa-a649-474f-bea5-618d074c31b9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11815424","allele":{"id":"https://genegraph.clinicalgenome.org/r/b65476fd-dae5-4cb7-ad03-1284f7cd11aa"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/4a06e23e-04ba-4b42-95ca-50524f50c3ad"}},{"id":"https://genegraph.clinicalgenome.org/r/7d49e2b7-d267-4fea-9b41-adf2ffd2f340_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24062880","rdfs:label":"Wells et al family","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/7d49e2b7-d267-4fea-9b41-adf2ffd2f340","type":"Family","rdfs:label":"Wells et al family","member":{"id":"https://genegraph.clinicalgenome.org/r/0981e6d7-cdcc-43ac-bfa4-d7ecf2faf263","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24062880","rdfs:label":"Wells et al family proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":69,"allele":{"id":"https://genegraph.clinicalgenome.org/r/cbff88bf-a36e-4a4d-a510-32b03d993ebf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.3(VCL):c.2444A>G (p.Lys815Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA136745"}},"detectionMethod":"Targeted gene panel comprising 19 genes","firstTestingMethod":"Next generation sequencing panels","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d407719c-39bc-44a2-a9c0-28cb65a1435a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24062880","allele":{"id":"https://genegraph.clinicalgenome.org/r/cbff88bf-a36e-4a4d-a510-32b03d993ebf"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/0981e6d7-cdcc-43ac-bfa4-d7ecf2faf263"}},{"id":"https://genegraph.clinicalgenome.org/r/8e80a787-bad2-45d1-b78e-9729fae23acc_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37548861","rdfs:label":"Zahavic_family 4","family":{"id":"https://genegraph.clinicalgenome.org/r/8e80a787-bad2-45d1-b78e-9729fae23acc","type":"Family","rdfs:label":"Zahavic_family 4","member":{"id":"https://genegraph.clinicalgenome.org/r/bf1f185a-e74d-4c60-9b3a-3bf6ad3cae07","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37548861","rdfs:label":"Zahavic_IV","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5e4a7f4c-6d03-4cc2-9b58-3c18ec5a2e1e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.3(VCL):c.670dup (p.Glu224GlyfsTer17)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10576823"}},"detectionMethod":"Whole genome sequencing with variants in VCL confirmed by clinical genetic testing. Sequencing workflow was previously reported in paper PMID: 35288587.","firstTestingMethod":"Whole genome shotgun sequencing","secondTestingMethod":"Next generation sequencing panels","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/a208ff01-a6a2-4a19-983f-9245981c4f9b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37548861","allele":{"id":"https://genegraph.clinicalgenome.org/r/5e4a7f4c-6d03-4cc2-9b58-3c18ec5a2e1e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/bf1f185a-e74d-4c60-9b3a-3bf6ad3cae07"}},{"id":"https://genegraph.clinicalgenome.org/r/c94b4c20-93a8-4efc-a5ae-487078377971_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11815424","rdfs:label":"K-1702","family":{"id":"https://genegraph.clinicalgenome.org/r/c94b4c20-93a8-4efc-a5ae-487078377971","type":"Family","rdfs:label":"K-1702","member":{"id":"https://genegraph.clinicalgenome.org/r/00c28737-d75b-4da4-85c2-c3bb930557a2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11815424","rdfs:label":"K-1702 - II.1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":39,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c1685c38-730c-4c2b-a713-a668f31e2a8d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"VCL, 3-BP DEL, 2862GTT","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12196"}},"detectionMethod":"Oligonucleotide primers were designed to amplify the coding and splice junction regions of the metavinculin-specific insert of vinculin (exon 19 of the VCL gene). Variants in ACTC1 and TMP1 were excluded previously.","firstTestingMethod":"SSCP","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d3698cc2-36e0-4240-b88c-fe20757591c9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11815424","allele":{"id":"https://genegraph.clinicalgenome.org/r/c1685c38-730c-4c2b-a713-a668f31e2a8d"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/00c28737-d75b-4da4-85c2-c3bb930557a2"}},{"id":"https://genegraph.clinicalgenome.org/r/9942b88d-262a-4bcc-b8ba-846270cc31ff_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37548861","rdfs:label":"Zahavic_family 5","family":{"id":"https://genegraph.clinicalgenome.org/r/9942b88d-262a-4bcc-b8ba-846270cc31ff","type":"Family","rdfs:label":"Zahavic_family 5","member":{"id":"https://genegraph.clinicalgenome.org/r/65d1f6de-1fac-432a-81c1-ec49dc665898","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37548861","rdfs:label":"Zahavic_V","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e3b6757-74cf-448c-9b63-5cdeef68c271","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.3(VCL):c.313C>T (p.Arg105Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA261758"}},"detectionMethod":"Whole genome sequencing with variants in VCL confirmed by clinical genetic testing. Sequencing workflow was previously reported in paper PMID: 35288587.","firstTestingMethod":"Whole genome shotgun sequencing","secondTestingMethod":"Next generation sequencing panels","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/c0416031-9883-4ab6-befa-207fcfc84063_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37548861","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e3b6757-74cf-448c-9b63-5cdeef68c271"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/65d1f6de-1fac-432a-81c1-ec49dc665898"}},{"id":"https://genegraph.clinicalgenome.org/r/ce2bfffd-f077-47a4-8bbf-194ba60bc4ce_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37548861","rdfs:label":"Zahavic_family 1","family":{"id":"https://genegraph.clinicalgenome.org/r/ce2bfffd-f077-47a4-8bbf-194ba60bc4ce","type":"Family","rdfs:label":"Zahavic_family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/d89c9183-f823-473e-bf67-63f31a44ccd1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37548861","rdfs:label":"Zahavic_Ia","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":5,"allele":{"id":"https://genegraph.clinicalgenome.org/r/75924ffd-76b9-4992-a783-fc43711c9bbc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.3(VCL):c.1639C>T (p.Arg547Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA261755"}},"detectionMethod":"Whole genome sequencing with variants in VCL confirmed by clinical genetic testing. Sequencing workflow was previously reported in paper PMID: 35288587.","firstTestingMethod":"Whole genome shotgun sequencing","secondTestingMethod":"Next generation sequencing panels","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/0c1886c0-85ca-441a-828e-aa0317ef0b98_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37548861","allele":{"id":"https://genegraph.clinicalgenome.org/r/75924ffd-76b9-4992-a783-fc43711c9bbc"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/d89c9183-f823-473e-bf67-63f31a44ccd1"}},{"id":"https://genegraph.clinicalgenome.org/r/a655d33c-ac4a-4953-acc5-461ad07b4854_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37548861","rdfs:label":"Zahavic_family 3","family":{"id":"https://genegraph.clinicalgenome.org/r/a655d33c-ac4a-4953-acc5-461ad07b4854","type":"Family","rdfs:label":"Zahavic_family 3","member":{"id":"https://genegraph.clinicalgenome.org/r/d7b60059-2819-4294-8342-f6972347d3bf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37548861","rdfs:label":"Zahavic_III","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/75586f29-abf7-47ad-a2b0-88bab8d8956f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000010.11:g.74112113del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2499220378"}},"detectionMethod":"Whole genome sequencing with variants in VCL confirmed by clinical genetic testing. Sequencing workflow was previously reported in paper PMID: 35288587.","firstTestingMethod":"Whole genome shotgun sequencing","secondTestingMethod":"Next generation sequencing panels","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/fa811a29-d277-4122-92cb-4452722d6a8f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37548861","allele":{"id":"https://genegraph.clinicalgenome.org/r/75586f29-abf7-47ad-a2b0-88bab8d8956f"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/d7b60059-2819-4294-8342-f6972347d3bf"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/8f250273-59a0-4187-9a01-ea80788544a2","type":"EvidenceLine","dc:description":"No evidence in support of variant's impact. Enrichment of VCL missense variants in DCM vs controls never demonstrated.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8f250273-59a0-4187-9a01-ea80788544a2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31983221","allele":{"id":"https://genegraph.clinicalgenome.org/r/63a43b59-e032-4444-af11-d2855ae4e576","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.3(VCL):c.626T>A (p.Met209Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/626753"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/cd37e087-ac61-4909-abd6-fd5d91ee196e","type":"EvidenceLine","dc:description":"The frequency of this variant is 0.0005 in Africans in gnomAD (12/24968), there is no functional data in support and no family information. However, the same variant is found also in another unrelated proband in the same study (proband 9, tested on 62 genes). Proband 9 not scored as included in the Mazzarotto et al case-control study (PMID 31983221).","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd37e087-ac61-4909-abd6-fd5d91ee196e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32516855","allele":{"id":"https://genegraph.clinicalgenome.org/r/d0054278-6f2a-497d-be72-3b81d8ed5945","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.3(VCL):c.2828_2829del (p.Pro943ArgfsTer9)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA335643"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/5f4e44e4-b87a-49d7-8a09-9a216e06c56f","type":"EvidenceLine","dc:description":"No evidence in support of variant's impact. Enrichment of VCL missense variants in DCM vs controls never demonstrated.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5f4e44e4-b87a-49d7-8a09-9a216e06c56f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31983221","allele":{"id":"https://genegraph.clinicalgenome.org/r/2d27ad87-9d5e-4a5a-85a4-7f154ed4832b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.3(VCL):c.688C>T (p.Arg230Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA136805"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/277a8855-e3e9-49cf-873f-0f9d70f32026","type":"EvidenceLine","dc:description":"Variant scored 0.1 on a different proband, due to its apparent enrichment in DCM (3 of 1040 probands carry it in this cohort), in spite a general enrichment of VCL missense variants in DCM has never been demonstrated.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/277a8855-e3e9-49cf-873f-0f9d70f32026_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31983221","allele":{"id":"https://genegraph.clinicalgenome.org/r/2dcb1ab4-f8f8-4752-95f1-63408f567dfe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.3(VCL):c.1195A>C (p.Asn399His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5562950"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/0ab46174-8f28-43d3-acb4-1e21c3206d21","type":"EvidenceLine","dc:description":"Proband reported with greater detail in additional publication, PMID: 37548861","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ab46174-8f28-43d3-acb4-1e21c3206d21_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37477868","allele":{"id":"https://genegraph.clinicalgenome.org/r/75586f29-abf7-47ad-a2b0-88bab8d8956f"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/574fff3e-4cc9-45db-b300-0530f6784c38","type":"EvidenceLine","dc:description":"Proband screened with 24 gene panel excluding several moderate or greater evidence genes for DCM (TTN, BAG3, FLNC, TNNC1, JPH2, NEXN). Additionally, no supporting evidence for missense variant. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/574fff3e-4cc9-45db-b300-0530f6784c38_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35284542","allele":{"id":"https://genegraph.clinicalgenome.org/r/375b2ad8-ef0b-429a-8ee7-1499686a8630","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.3(VCL):c.625A>T (p.Met209Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5562829"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/19a091fc-a246-48d7-981d-4fb882103556","type":"EvidenceLine","dc:description":"No functional data in support, and no family information. Furthermore, the same individual is reported to have remodelled to a \"mild LV dilation\" in PMID 32516855, based on a 2012 MRI scan (while this paper refers to an echo diagnosis from 2009, confirmed by multiple internal reports).","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/19a091fc-a246-48d7-981d-4fb882103556_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31983221","allele":{"id":"https://genegraph.clinicalgenome.org/r/66b1c54b-097a-4ec5-87f1-94ce7cba10fa","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003373.4(VCL):c.2131+1del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA594387970"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6988cf1d-77fc-45a4-86e5-b269af19f4ba","type":"EvidenceLine","dc:description":"No functional data in support, and no family information.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6988cf1d-77fc-45a4-86e5-b269af19f4ba_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32516855","allele":{"id":"https://genegraph.clinicalgenome.org/r/de3bb223-4099-45b8-9697-ef4ca7f097b2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.3(VCL):c.3163C>T (p.Arg1055Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA273659"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d3698cc2-36e0-4240-b88c-fe20757591c9","type":"EvidenceLine","dc:description":"Viscometry analysis showed that the variant is associated with strong actin bundling activity. However, the deletion of the adjacent residue (another leucine, p.Leu955del), which has an identical effect on the protein, has a MAF of 0.000407 in gnomAD.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d3698cc2-36e0-4240-b88c-fe20757591c9_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d3698cc2-36e0-4240-b88c-fe20757591c9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Viscometry analysis showed that the variant is associated with strong actin bundling activity.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/6dd9aa72-aac2-40aa-b268-018cff8b6e29","type":"EvidenceLine","dc:description":"No evidence in support of variant's impact. Enrichment of VCL missense variants in DCM vs controls never demonstrated.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6dd9aa72-aac2-40aa-b268-018cff8b6e29_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31983221","allele":{"id":"https://genegraph.clinicalgenome.org/r/1cee8959-8bce-44be-8050-d4030379cc22","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003373.4(VCL):c.2746-2238T>C (p.=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377264593"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/93784027-3dac-4a13-b3f9-943c7591e262","type":"EvidenceLine","dc:description":"No evidence in support of variant's impact. Enrichment of VCL missense variants in DCM vs controls never demonstrated.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/93784027-3dac-4a13-b3f9-943c7591e262_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31983221","allele":{"id":"https://genegraph.clinicalgenome.org/r/36d6db17-7a2d-4ec1-8351-bc2fb32b21ae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003373.4(VCL):c.437C>T (p.Thr146Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377266502"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/cd55b404-d2e9-4a59-b3d6-ba0c93d302be","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd55b404-d2e9-4a59-b3d6-ba0c93d302be_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/cd55b404-d2e9-4a59-b3d6-ba0c93d302be_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Authors show, using viscometry analysis, that the variant is associated with strong actin bundling activity. This is confirmed using electron microscopy. They also demonstrate that the variant causes significant disruption of intercalated discs. The MAF of the p.Arg975Trp variant in gnomAD is 0.00009943.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e70c2ba5-0578-4600-9137-14bb06255c3c","type":"EvidenceLine","dc:description":"No family info, and no functional evidence in support of the variant's impact. Phenotype described as \"severe LV dilation with impaired function\" (rather than \"DCM\").","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e70c2ba5-0578-4600-9137-14bb06255c3c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32516855","allele":{"id":"https://genegraph.clinicalgenome.org/r/79dec50c-9490-4aeb-822b-d0f61731b409","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003373.4(VCL):c.2328del (p.Lys778SerfsTer6)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139532493"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e681ab1b-f937-46c6-b941-06b7da34d03b","type":"EvidenceLine","dc:description":"Proband reported with additional detail in separate publication, PMID: 37548861","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e681ab1b-f937-46c6-b941-06b7da34d03b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37477868","allele":{"id":"https://genegraph.clinicalgenome.org/r/25009b5b-662a-4941-ae01-abf91511da82"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/29b24033-922d-45a7-81b0-e6e77e0ae7cb","type":"EvidenceLine","dc:description":"Proband screened with 24 gene panel excluding several moderate or greater evidence genes for DCM (TTN, BAG3, FLNC, TNNC1, JPH2, NEXN). Additionally, no supporting evidence for missense variant. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/29b24033-922d-45a7-81b0-e6e77e0ae7cb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35284542","allele":{"id":"https://genegraph.clinicalgenome.org/r/e5f82f24-e6cd-4ab3-9428-f96d820ae6be","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.3(VCL):c.1192C>T (p.Pro398Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA238358"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/57691fff-040e-48cb-9e97-fd60c8c5107b","type":"EvidenceLine","dc:description":"No functional data in support and some definitive DCM genes not screened (TTN, RBM20, TNNC1). However, the proband's father carries the variant and is affected.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/57691fff-040e-48cb-9e97-fd60c8c5107b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32516855","allele":{"id":"https://genegraph.clinicalgenome.org/r/25009b5b-662a-4941-ae01-abf91511da82"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/a02f814a-f427-4b31-9321-47522e39b0fa","type":"EvidenceLine","dc:description":"Variant scored in spite of the lack of supportive evidence (functional, segregation etc), due to its recurrence (3 of 1040 probands here vs 15 of 141383 gnomAD individuals).","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a02f814a-f427-4b31-9321-47522e39b0fa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31983221","allele":{"id":"https://genegraph.clinicalgenome.org/r/2dcb1ab4-f8f8-4752-95f1-63408f567dfe"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/062e483d-6f15-4096-9917-a92ce6725ea6","type":"EvidenceLine","dc:description":"Variant not scored, no additional evidence to support pathogenicity for missense variants in VCL and no supportive evidence available for this case. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/062e483d-6f15-4096-9917-a92ce6725ea6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26458567","allele":{"id":"https://genegraph.clinicalgenome.org/r/375b2ad8-ef0b-429a-8ee7-1499686a8630"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/2d46699a-5f8c-460d-9233-bec4e2ecf560_cc_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/68bf21df-039c-47a2-88dc-88cfb4ccea0c","type":"EvidenceLine","dc:description":"The study is powered, the enrichment is highly significant also after Bonferroni correction for multiple testing, and specific to predicted loss-of-function variants. Activation of PVS1_moderate criteria for predicted loss-of-function variants is suggestes in the DCM-specific variant interpretation guidelines issued by Clingen, and VCL is characterized by a moderately low o/e ratio in gnomAD (0.25), suggesting intolerance towards this type of variants. On the other hand, cohorts are not matched and a population cohort (ExAC) is used as a proxy for a control set.","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/68bf21df-039c-47a2-88dc-88cfb4ccea0c_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31983221","rdfs:label":"Mazzarotto2020","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/15c318fb-bd2a-4907-8fff-881afba8a906","type":"Cohort","allGenotypedSequenced":773,"alleleFrequency":0.007761966364812419,"detectionMethod":"Various panels targeting up to 45 genes. Each gene was sequenced in 135-1498 patients. VCL was sequenced in 773 patients.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/68bf21df-039c-47a2-88dc-88cfb4ccea0c_cc_evidence_item"}],"numWithVariant":6,"relatedCondition":{"id":"obo:MONDO_0005021"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/c7e99d92-1b6a-462c-abfe-a3f33b4595e2","type":"Cohort","allGenotypedSequenced":60244,"alleleFrequency":0.0002987849412389616,"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/68bf21df-039c-47a2-88dc-88cfb4ccea0c_cc_evidence_item"}],"numWithVariant":18},"lowerConfidenceLimit":10.4,"method":{"id":"cg:AggregateVariantAnalysis"},"pValue":0.0000251602,"statisticalSignificanceType":"","statisticalSignificanceValue":26.2,"statisticalSignificanceValueType":"Odds Ratio","upperConfidenceLimit":66.1}],"specifiedBy":"GeneValidityCaseControlAggregateVariantAnalysisCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallCaseControlEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/43d62918-35d9-44e6-af02-721e18d43e35","type":"EvidenceLine","dc:description":"No evidence in support of variant's impact. Enrichment of VCL missense variants in DCM vs controls never demonstrated.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/43d62918-35d9-44e6-af02-721e18d43e35_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31983221","allele":{"id":"https://genegraph.clinicalgenome.org/r/14c98e6f-d40e-4b0d-aef0-e08c798172f0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.3(VCL):c.2468G>A (p.Arg823Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA080873"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d2d3385b-ae58-4a75-98fc-971382e863eb","type":"EvidenceLine","dc:description":"No functional data in support and no family information. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d2d3385b-ae58-4a75-98fc-971382e863eb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32516855","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e38849a-f7cc-4a4b-8980-e371131a4b50","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003373.4(VCL):c.1543+1G>T (p.=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377274043"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/0c1886c0-85ca-441a-828e-aa0317ef0b98","type":"EvidenceLine","dc:description":"Downgraded due to the presence of 2 genotype positive, phenotype negative individuals in the family. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0c1886c0-85ca-441a-828e-aa0317ef0b98_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/fa811a29-d277-4122-92cb-4452722d6a8f","type":"EvidenceLine","dc:description":"Scored as 1 pt to remain consistent with scoring of this variant in a proband in Hawley et. al","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fa811a29-d277-4122-92cb-4452722d6a8f_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e63c0f2f-d1eb-4a55-8963-3aaaa9bd2fdf","type":"EvidenceLine","dc:description":"Scored 1 pt to keep scoring consistent with scoring of probands in Hawley et. al, where they carried the same variant. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e63c0f2f-d1eb-4a55-8963-3aaaa9bd2fdf_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c0416031-9883-4ab6-befa-207fcfc84063","type":"EvidenceLine","dc:description":"Scored as one point to remain consistent with scoring of this variant in probands in Hawley et. al","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c0416031-9883-4ab6-befa-207fcfc84063_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/8fb5423b-6426-4f23-9a1a-cc9c5450714a","type":"EvidenceLine","dc:description":"No evidence in support of variant's impact. Enrichment of VCL missense variants in DCM vs controls never demonstrated.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8fb5423b-6426-4f23-9a1a-cc9c5450714a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31983221","allele":{"id":"https://genegraph.clinicalgenome.org/r/4fd3e5f5-8ff3-47a0-8ec7-c40390f55c7b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.3(VCL):c.224C>T (p.Pro75Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA335607"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/2ce44c0e-b0b4-447f-b0e6-17a43b661c69","type":"EvidenceLine","dc:description":"No comment on presence or absence of other variants, missense variant without supporting evidence. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2ce44c0e-b0b4-447f-b0e6-17a43b661c69_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37477868","allele":{"id":"https://genegraph.clinicalgenome.org/r/05d10df7-f51d-4dba-bc9a-d6a453c05cdf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.3(VCL):c.1637A>T (p.Asp546Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377274747"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/0be10fe3-4318-48bf-8e83-9cebdd277195","type":"EvidenceLine","dc:description":"Variant scored 0.1 on a different proband, due to its apparent enrichment in DCM (3 of 1040 probands carry it in this cohort), in spite a general enrichment of VCL missense variants in DCM has never been demonstrated.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0be10fe3-4318-48bf-8e83-9cebdd277195_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31983221","allele":{"id":"https://genegraph.clinicalgenome.org/r/2dcb1ab4-f8f8-4752-95f1-63408f567dfe"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e109764d-e5d3-4a1e-9afd-21cd015ae65d","type":"EvidenceLine","dc:description":"No evidence in support of variant's impact. Enrichment of VCL missense variants in DCM vs controls never demonstrated.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e109764d-e5d3-4a1e-9afd-21cd015ae65d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31983221","allele":{"id":"https://genegraph.clinicalgenome.org/r/66dcb50d-4d1c-4e7d-9b34-91f5be5fc132","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003373.4(VCL):c.1514A>G (p.Asp505Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377273978"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7542415c-4f84-42f1-9d42-426b059d6b69","type":"EvidenceLine","dc:description":"No evidence in support of variant's impact. Enrichment of VCL missense variants in DCM vs controls never demonstrated.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7542415c-4f84-42f1-9d42-426b059d6b69_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31983221","allele":{"id":"https://genegraph.clinicalgenome.org/r/3a83cc7e-5baa-4c0a-af45-5eb743cc7a7d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003373.4(VCL):c.2755A>G (p.Ile919Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377266292"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/1ca91faa-a649-474f-bea5-618d074c31b9","type":"EvidenceLine","dc:description":", but this variant has a MAF of 0.0137 in gnomAD (too common to consider it a potential monogenic cause of DCM). In addition, authors report this variant in 1/500 controls, and propose it as a 'risk-conferring polymorphism' as the proband was characterized by 'ventricular dilation' (although he had been diagnosed with DCM previously) and his social history was notable for alcohol abuse.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1ca91faa-a649-474f-bea5-618d074c31b9_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/1ca91faa-a649-474f-bea5-618d074c31b9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The authors do provide evidence in support of a functional impact for the p.Ala934Val variant (using viscometry assays).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/a208ff01-a6a2-4a19-983f-9245981c4f9b","type":"EvidenceLine","dc:description":"Downgraded due to presence of an adult genotype positive phenotype negative individual in the family.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a208ff01-a6a2-4a19-983f-9245981c4f9b_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/85945876-6471-4880-a8d1-d6bc589ceffa","type":"EvidenceLine","dc:description":"No comment on presence or absence of other variants, missense variants without supporting evidence.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/85945876-6471-4880-a8d1-d6bc589ceffa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37477868","allele":{"id":"https://genegraph.clinicalgenome.org/r/b8f3d8e4-7615-4bc0-aa7b-4c9abaee5345","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.3(VCL):c.2038C>T (p.Arg680Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5563158"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/5861fbe6-ece6-4f2a-bfcc-4f5f12a108db","type":"EvidenceLine","dc:description":"Variant was not scored, MAF of 0.0005749 in gnomAD v4.1 > 0.0001","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5861fbe6-ece6-4f2a-bfcc-4f5f12a108db_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26406308","allele":{"id":"https://genegraph.clinicalgenome.org/r/c77de238-0385-4310-8068-ae304cf27a0d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.3(VCL):c.1237G>A (p.Ala413Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA136682"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e1b0cbb1-d21c-4bbf-a8a9-bd36b3efe619","type":"EvidenceLine","dc:description":"Variant present in additional publication with more evidence, PMID: 37548861","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e1b0cbb1-d21c-4bbf-a8a9-bd36b3efe619_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37477868","allele":{"id":"https://genegraph.clinicalgenome.org/r/75924ffd-76b9-4992-a783-fc43711c9bbc"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d407719c-39bc-44a2-a9c0-28cb65a1435a","type":"EvidenceLine","dc:description":"Co-segregation with DCM considered supportive evidence for this missense variant in VCL","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d407719c-39bc-44a2-a9c0-28cb65a1435a_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/e7412ece-7dad-452a-87bf-c1cc799139b7","type":"EvidenceLine","dc:description":"No functional data in support, and no family information.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e7412ece-7dad-452a-87bf-c1cc799139b7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32516855","allele":{"id":"https://genegraph.clinicalgenome.org/r/797f9f5a-33f0-4d02-a107-5d31ac6ab461","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014000.3(VCL):c.562C>T (p.Arg188Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA261761"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":11.2}],"evidenceStrength":"Strong","sequence":11065,"specifiedBy":"GeneValidityCriteria10","strengthScore":13.7,"subject":{"id":"https://genegraph.clinicalgenome.org/r/eKA9eW6wyCk","type":"GeneValidityProposition","disease":"obo:MONDO_0005021","gene":"hgnc:12665","modeOfInheritance":"obo:HP_0000006"},"version":"2.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_2d46699a-5f8c-460d-9233-bec4e2ecf560-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}